In this scoping review, we investigated 17 AI chatbots related to the COVID-19 pandemic. The majority of chatbots spoke in English when interacting with users; other languages, such as German, Chinese, and French, were less frequently used. This is consistent with the fact that the United States, followed by India and Canada, had the greatest proportion of chatbot development. Chatbots created in India were often multilingual. This is due to the language diversity in the country (
7,
29,
31). The majority of the chatbots were designed for the general population and were less targeted to specific groups. This generality can be attributed to the fact that COVID-19 is not limited to a specific group and has affected the general population (
1). However, based on the features of AI chatbots, this novel technology can be useful in providing better health services to high-risk groups such as elderly people.
Our review identified the eight most common use cases of AI chatbots during the COVID-19 pandemic. Enhancing public awareness about COVID-19 has a significant effect on reducing and preventing the spread of the disease (
43). More than 75% of chatbots had the task of disseminating information and educating users about COVID-19. These chatbots answered users’ questions round-the-clock and provided them with necessary information. Lack of readily available, accurate information from reliable sources during the COVID-19 outbreak led to the rapid spread of rumors and false information (
30,
44). Some AI chatbots were created to address this issue by delivering trustworthy information and spotting rumors and false news (
33,
36). Dissemination of up-to-date, reliable, correct, and high-quality information can greatly enhance the usefulness of chatbots. Information and findings related to COVID-19 are rapidly evolving, so the information provided by chatbots must be continuously updated and validated.
Given the importance of early identification of people with COVID-19 (
45), some chatbots were developed for the assessment and triage of individuals. These chatbots were often created by governments and organizations such as WHO and CDC to screen people in the community. They usually assess the user’s risk of contracting COVID-19 based on common diagnostic guidelines and employ machine learning techniques. Using these chatbots has many benefits, including reducing unnecessary visits to healthcare centers, promoting social distancing, optimizing the use of health resources, preventing virus transmission, and enabling early identification of patients. However, the diagnostic accuracy of chatbots in COVID-19 diagnosis remains one of the main challenges. Munsch and colleagues have shown that chatbots exhibit different sensitivity and specificity in relation to the diagnosis of COVID-19 (
46). Therefore, the diagnostic performance of chatbots must be evaluated.
Providing care services to patients who are in home quarantine and continuously monitoring their physical and mental condition is important for better management of COVID-19 (
47). Some chatbots were designed to support COVID-19 patients. These chatbots provide telemonitoring and care services and allow users to communicate online with healthcare providers and medical centers (
28). This can improve the quality of care services, enhance patient safety, and reduce violations of home quarantine.
COVID-19 vaccines play an effective role in reducing the mortality rate and the spread of the virus. However, rumors about the side effects of the vaccines and vaccine hesitancy pose significant challenges (
46). According to the WHO, vaccine hesitancy is considered one of the 10 major threats to public health (
39). Some chatbots are developed to provide services about the COVID-19 vaccine, such as answering user’s questions. These chatbots can be effective in reducing vaccine hesitancy and encouraging people to get vaccinated.
While AI chatbots have the potential to improve healthcare services during the pandemic, Using AI chatbots to help combat the prevalence of COVID-19 presented several main challenges (
25,
28,
33,
34). These challenges include ensuring the accuracy of the information, accessibility, and equitable access, language barriers, handling a high volume of queries, integration with healthcare systems, privacy and data concerns, user trust, monitoring and evaluation of the chatbot’s performance, ongoing maintenance and updates, and user education. Addressing these challenges requires collaboration among AI developers, healthcare professionals, and public health agencies to develop effective solutions.
AI chatbots were also examined from technical aspects. On a variety of platforms, including mobile, web, and social media, AI chatbots have been implemented. The majority of chatbots were mobile-based (
7,
27,
30-
34,
36,
40). This can be due to the popularity of smartphones and easy access to this technology. NLU component is an essential part of every AI chatbot (
42). Therefore, all chatbots use NLU techniques to comprehend user input in natural language and respond to their requests. Because it takes NLP skills to create an NLU from scratch, chatbot developers typically employ NLU platforms (
42). Numerous NLU platforms have recently been made available as pre-built NLU components for chatbots. Google DialogFlow, Rasa, IBM Watson, and Microsoft LUIS platforms are the four most common platforms for creating chatbots (
42). In 52% of the reviewed AI chatbots, the Rasa framework, IBM Watson, and Google DialogFlow platforms were used. Despite the advantages of using NLU platforms, each platform has its features and limitations that should be considered when developing a chatbot (
42).
User-chatbot interaction design is an important factor in chatbot efficiency (
48). Therefore, we investigated the conversational style of chatbots. The input type in most chatbots was text. In more than 80% of these chatbots, the user can use free text input and have a natural language conversation. AI chatbots use various NLP or NLU techniques to process and understand user requests. Therefore, the user can enter his request in the chatbot in natural language and in the form of free text. However, the results of a study have shown that most of the chatbots were not free text, and the user could only choose from predetermined and controlled options (
23). This may be due to most of the reviewed chatbots being rule-based. Some chatbots were based on voice input in addition to text. These chatbots used different voice recognition techniques to understand the input information. For example, three chatbots used voice recognition technology from IBM (
18,
19) and Amazon (
24). The possibility of user interaction in the form of free text or voice can improve the usability of chatbots and increase ease of use, especially for older adults and disabled people. However, misunderstanding of user requests and language limitations are major issues in these chatbots. The output format of most chatbots was text, but other formats, such as audio, medical catalogs, and educational videos, were also used. Using different and appropriate output formats can help facilitate better and more effective user chatbot conversations, especially in educational and informational chatbots. CoronaGO is an example of these chatbots that provide necessary training related to self-care against COVID-19 to users in multimedia formats (
29). The chatbot’s ability to understand user emotions is important, especially in mental health chatbots. With the advancements in artificial intelligence, it is envisaged that AI chatbots will be able to improve the social and emotional aspects of the conversation.
5.1. Conclusions
In conclusion, our scoping review identified eight common application categories of AI chatbots related to COVID-19. Most of the developed chatbots have a preventive role and are commonly utilized for information dissemination, education, and self-assessment. While AI chatbots have the potential to improve healthcare access and quality by providing personalized, accessible, and timely support and information to patients, it is important to acknowledge the potential limitations and challenges associated with their use. Further research is needed to investigate the usability and effectiveness of AI chatbots in different healthcare areas, including their impact on clinical outcomes and user experience. More than half of the AI chatbots were designed based on widely used NLU platforms. Because this method makes chatbot development easier and frees developers from having to deal with technological concerns, using NLU platforms can be advantageous for the development of AI chatbots in the healthcare industry.
Overall, while AI chatbots offer a promising approach to improving healthcare services, further research is needed to understand their benefits and limitations in more depth. With advancements in AI, it appears that AI chatbots such as ChatGPT can mark a bright future in the healthcare domain. However, their efficacy and effectiveness need to be evaluated through rigorous research.